Micro insulin pump for mobile diabetes management
The Cellnovo system is the world’s first mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated blood glucose meter and automatic connectivity.
The system allows optimal management of insulin injections whilst ensuring extensive freedom of movement for Type 1 diabetes patients. The system has CE mark, and is on the market in the United Kingdom and several European countries.
CEO Sophie Baratte
Advent invested in the Series A in 2008. Cellnovo listed on Euronext in July 2015 (EPA:CLNV).
Success of Cellnovo’s IPO with €31.6 million raised on Euronext in Paris
Press Release. Offer price set at €10.63 per share Market capitalization of €113.6 million Funds to develop production capabilities and accelerate commercial expansion Paris, France, July 9, 2015 –…Read More
Cellnovo launches first Mobile Diabetes Management System at the ATTD Conference in Vienna, Austria
Press Release. Real-time tracking - an industry first for insulin pump technology Swansea, 5 February 2014 – Cellnovo, the leading innovator in Mobile Diabetes Management technology, today announces the…Read More
Cellnovo launches world’s first mobile-connected diabetes management system
Press Release. LONDON UK/BARCELONA, SPAIN – February 9, 2012 – Cellnovo today announced both the launch of the world’s only mobile-connected diabetes management system, and the start of the…Read More